Genor Biopharma Holdings Limited (6998.HK)

HKD 1.66

(-5.68%)

Total Assets Summary of Genor Biopharma Holdings Limited

Genor Biopharma Holdings Limited's latest annual total assets in 2023 was 1.44 Billion CNY , down -31.59% from previous year.
Genor Biopharma Holdings Limited's latest quarterly total assets in 2024 Q2 was 1.27 Billion CNY , down 0.0% from previous quarter.
Genor Biopharma Holdings Limited reported annual total assets of 2.11 Billion CNY in 2022, down -26.12% from previous year.
Genor Biopharma Holdings Limited reported annual total assets of 2.86 Billion CNY in 2021, down -19.89% from previous year.
Genor Biopharma Holdings Limited reported quarterly total assets of 1.27 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
Genor Biopharma Holdings Limited reported quarterly total assets of 1.83 Billion CNY for 2023 Q1, down -13.27% from previous quarter.

Annual Total Assets Chart of Genor Biopharma Holdings Limited (2023 - 2018)

Historical Annual Total Assets of Genor Biopharma Holdings Limited (2023 - 2018)

Year	Total Assets	Total Assets Growth
2023	1.44 Billion CNY	-31.59%
2022	2.11 Billion CNY	-26.12%
2021	2.86 Billion CNY	-19.89%
2020	3.57 Billion CNY	387.62%
2019	732.83 Million CNY	-25.8%
2018	987.66 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	1.27 Billion CNY	-11.93%
2024 Q2	1.27 Billion CNY	0.0%
2023 Q1	1.83 Billion CNY	-13.27%
2023 FY	1.44 Billion CNY	-31.59%
2023 Q4	1.44 Billion CNY	0.0%
2023 Q3	1.44 Billion CNY	-21.13%
2023 Q2	1.83 Billion CNY	0.0%
2022 Q2	2.42 Billion CNY	0.0%
2022 Q1	2.42 Billion CNY	-15.2%
2022 Q4	2.11 Billion CNY	0.0%
2022 FY	2.11 Billion CNY	-26.12%
2022 Q3	2.11 Billion CNY	-12.88%
2021 FY	2.86 Billion CNY	-19.89%
2021 Q1	3.27 Billion CNY	-8.38%
2021 Q4	2.86 Billion CNY	0.0%
2021 Q3	2.86 Billion CNY	-12.56%
2021 Q2	3.27 Billion CNY	0.0%
2020 FY	3.57 Billion CNY	387.62%
2020 Q1	679.18 Million CNY	0.0%
2020 Q2	- CNY	-100.0%
2020 Q4	3.57 Billion CNY	0.0%
2020 Q3	3.57 Billion CNY	0.0%
2019 Q1	- CNY	0.0%
2019 FY	732.83 Million CNY	-25.8%
2018 FY	987.66 Million CNY	0.0%

Peer Total Assets Comparison of Genor Biopharma Holdings Limited

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-252.904%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	87.136%